A Feasibility Study of the Impact on Blood Pressure Control of Supplementing Community Pharmacist Services With Structured Information on Blood Pressure and Its Treatment

Hypertension Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01939860
• Other study ID #: Warwick.123
• Status: Completed
• Phase: N/A
• First received: September 3, 2013
• Last updated: December 4, 2017
• Start date: January 2014
• Est. completion date: June 2014

Study information

• Verified date: December 2017
• Source: University of Warwick
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Hypertension is a major health problem, however its control is unsatisfactory. One of the reasons for such a high prevalence of this disease includes poor patient compliance to treatment. Approximately 30 % of newly diagnosed hypertensive patients stop taking their blood pressure medication by six months and 50% by 12 months.

The UK government is keen to encourage community pharmacists to play an active role in participation of services that can improve patient adherence to their medications. The New Medicines Service (NMS) and targeted Medicines Use Reviews (MUR) are established services which fund community pharmacists to review and explain medicine use to patients, with hypertension a common condition for which advice is given within these schemes. Within these schemes, advice is verbal and unstructured, with no specific written information provided on drugs or the disease being treated.

This study aims to determine whether structured information provided to participants verbally and in writing by community pharmacists about blood pressure and current medicine(s) within NMS and targeted MURs will be retained and will be associated with improved hypertension control. Participants will be recruited from people eligible for NMS and MURs and attending community pharmacies.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 56
• Est. completion date: June 2014
• Est. primary completion date: June 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1)18 or over 2) male or female 3) Have been started on any blood pressure medication

Exclusion Criteria:

1)Patients with English language problems

Related Conditions & MeSH terms

• Hypertension

Intervention

Other:
• Written and verbal patient education on hypertension and its treatment

Locations

Country	Name	City	State
United Kingdom	J P Goes chemist	Coventry

Sponsors (1)

Lead Sponsor	Collaborator
University of Warwick

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in systolic or diastolic blood pressure	Systolic and diastolic blood pressure will be measured and recorded in mm Hg using OMRON blood pressure monitors	1 year (trial would be stopped at 26 weeks if it is not possible to recruit any further participants
Secondary	change in the knowledge of hypertension		one year(trial would be stopped at 26 weeks if it is not possible to recruit any further participants)